+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Insulin resistance induced in dairy steers by tumor necrosis factor alpha is partially reversed by 2,4-thiazolidinedione

Insulin resistance induced in dairy steers by tumor necrosis factor alpha is partially reversed by 2,4-thiazolidinedione

Domestic animal endocrinology 21(1): 25-37

The aim of this study was to determine whether 2,4-thiazolidinedione (2,4-TZD) influences the effects of peripheral insulin action in steers given recombinant bovine tumor necrosis factor (TNF) alpha (rbTNF). Steers were treated once daily for 9 d (d0-d8) with either s.c. injection of rbTNF (2.5 microgram/kg), rbTNF + i.v. injection of 2,4-TZD (2.0 mg/kg), or s.c. injection of saline (control). The plasma glucose, NEFA, and insulin concentrations in the rbTNF-treated group increased compared to those in the control and rbTNF + 2,4-TZD groups, whereas glucagon concentration decreased. A single i.v. injection of insulin (0.2 U/kg), glucose (112.5 mg/kg), or growth hormone (GH)-releasing hormone (GHRH) (0.25 microgram/kg) was performed on d4, d6, and d8, respectively. In the insulin challenge, the net area under the glucose curve (AUC) was smaller in the rbTNF group than in the control and rbTNF + 2,4-TZD groups. In the glucose challenge, the net insulin AUC was smaller in rbTNF + 2,4-TZD group than in rbTNF group. In the GHRH challenge, there was no difference in GH responses to GHRH between the rbTNF and rbTNF + 2,4-TZD groups, respectively. We conclude that 2,4-TZD treatment partially reverses the impairment of peripheral insulin action caused by rbTNF injection in steers.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 003480041

Download citation: RISBibTeXText

PMID: 11524172

DOI: 10.1016/s0739-7240(01)00102-3

Related references

Mechanisms involved in tumor necrosis factor-alpha induction of insulin resistance and its reversal by thiazolidinedione(s). American Journal of the Medical Sciences 322(2): 75-78, 2001

Temporary reversal by topotecan of marked insulin resistance in a patient with myelodysplastic syndrome: case report and possible mechanism for tumor necrosis factor alpha (TNF-alpha)-induced insulin resistance. American Journal of Clinical Oncology 24(3): 279-282, 2001

An in vivo model for elucidation of the mechanism of tumor necrosis factor-alpha (TNF-alpha)-induced insulin resistance: evidence for differential regulation of insulin signaling by TNF-alpha. Endocrinology 139(12): 4928-4935, 1998

Mechanisms Involved in Tumor Necrosis Factor- Induction of Insulin Resistance and Its Reversal by Thiazolidinedione(s). The American Journal of the Medical Sciences 322(2): 75-78, 2001

Overcoming tumor necrosis factor-alpha resistance of human renal and ovarian carcinoma cells by combination treatment with buthionine sulfoximine and tumor necrosis factor-alpha. Role of tumor necrosis factor-alpha mRNA down-regulation in tumor cell sensitization. Cancer 73(3): 730-737, 1994

The association of tumor necrosis factor alpha receptor 2 and tumor necrosis factor alpha with insulin resistance and the influence of adipose tissue biomarkers in humans. Metabolism: Clinical and Experimental 59(4): 540-546, 2010

The mechanism of tumor necrosis factor-alpha (TNF-alpha) induced insulin resistance by variation in promoter region of TNF-alpha gene. Zhonghua Yi Xue Za Zhi 79(5): 343-345, 1999

Tumor necrosis factor-alpha causes insulin receptor substrate-2-mediated insulin resistance and inhibits insulin-induced adipogenesis in fetal brown adipocytes. Endocrinology 139(3): 1229-1238, 1998

Up-regulation of tumor necrosis factor-alpha converting enzyme may partially contribute to interferon-gamma-induced tumor necrosis factors-alpha secretion in human monocytic cells treated with alcohol. Journal of Investigative Medicine 47(2): 147A, 1999

Tumor necrosis factor-alpha- and hyperglycemia-induced insulin resistance. Evidence for different mechanisms and different effects on insulin signaling. Journal of Clinical Investigation 97(6): 1471-1477, 1996

Tumor necrosis factor-alpha-induced insulin resistance in adipocytes. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 223(2): 128-135, 2000

Insulin resistance induced by tumor necrosis factor-alpha in myocytes and brown adipocytes. Journal of Animal Science 86(14 Suppl): E94, 2008

Andrographolide attenuates tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes. Molecular and Cellular Endocrinology 332(1-2): 134-139, 2011

Protein-tyrosine phosphatase 1B-deficient myocytes show increased insulin sensitivity and protection against tumor necrosis factor-alpha-induced insulin resistance. Diabetes 56(2): 404-413, 2007

Troglitazone ameliorates insulin resistance and metabolic abnormalities induced by tumor necrosis factor alpha. International Journal of Obesity 22(Suppl. 3): S265, 1998